Casak, Sandra J.

United States Food and Drug Administration · Center for Drug Evaluation and Research

1 paper on CoChatORCID 0000-0001-5988-3985

Most cited papers

Verified
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Gandhy, S. U., Casak, S. J., Mushti, S. L., Cheng, J., Subramaniam, S., Zhao, H., Zhao, M., Bi, Y., Liu, G., Fan, J., et al. (2023) · Clinical Cancer Research
Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments
Cited by 25

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free